BCG vaccine of 2004 the vaccine is given to about 100 million children per year globally. The main use of BCG is for vaccination against tuberculosis. BCG vaccine can be administered after birth intradermally. BCG vaccination can cause a false positive Mantoux test, although a very high-grade reading is usually due to active disease. The most controversial aspect of BCG is the variable efficacy found in different clinical trials, which appears to depend on geography. Trials conducted in the UK have consistently shown a protective effect of 60 to 80%, but those conducted elsewhere have shown no protective effect, and efficacy appears
Inoculation needle slant culture to needle, the open end of the culture will be treated with flame and the cap will be replaced. An inoculation needle is used in the transfer of microbial organisms from plate culture to needle by first sterilizing the needle to prevent contaminants. The lid of the agar plate culture is then removed to allow the needle access to the microorganisms cultured on the agar plate. The lid is held hovering above the culture plate to prevent contamination from the surrounding environment. The inoculation needle after incineration is cooled down on an uninoculated region of the agar plate